How Gilead is positioning its COVID-19 drug against newer antivirals like Paxlovid By: MarketWatch April 27, 2022 at 09:32 AM EDT The company has an oral version of its COVID-19 drug Veklury in a clinical trial. Read More >> Related Stocks: AbbVie Gilead Sciences Merck & Co Pfizer